Evaluating the Associations Between Exposure to Tobacco Interventions During Inpatient Treatment and Substance Use Outcomes: Findings From a Natural Experiment.
Journal
Journal of addiction medicine
ISSN: 1935-3227
Titre abrégé: J Addict Med
Pays: Netherlands
ID NLM: 101306759
Informations de publication
Date de publication:
Historique:
pubmed:
22
9
2020
medline:
30
6
2021
entrez:
21
9
2020
Statut:
ppublish
Résumé
In this study, we took advantage of a natural experiment that occurred within a substance use disorders (SUD) treatment setting which first saw the implementation of an evidence-based practice (EBP) for tobacco cessation, followed by the implementation of a tobacco-free policy (TFP) that included a campus-wide tobacco ban. We sought to examine how implementation of the EBP and TFP was associated with substances use outcomes, in addition to tobacco use, up to 3-months posttreatment. Data were collected from patients in a substance use disorders treatment program at baseline, discharge, 1-, and 3-months posttreatment. Using a quasi-experimental design and generalized estimating equations, we modelled how patients' (N = 480) exposure to one of 3 interventions (1: treatment as usual [TAU], 2: EBP, and 3: EBP + TFP) was associated with overall abstinence from tobacco, alcohol, and other substances over time. Measures of tobacco use frequency, amount, and quit attempts were also modelled among a sub-sample of participants who self-reported using tobacco before treatment. Exposure to the EBP + TFP was associated with increased tobacco abstinence (odds ratio [OR] = 1.93, 95% confidence interval [CI] [1.29, 2.90]) over time, including decreases in tobacco use frequency (OR = 0.78, 95% CI [0.68, 0.89]) and amount (OR = 0.80, 95% CI [0.67, 0.96]), and increased in likelihood of making a quit attempt (OR = 1.75, 95% CI [1.10, 2.80]) compared to TAU. Exposure was not associated with alcohol and/or other substance use. Comprehensive tobacco interventions that include EBP + TFP can promote tobacco cessation and reduced tobacco use following inpatient SUD treatment, without adversely affecting the use of other substances.
Identifiants
pubmed: 32956163
pii: 01271255-202106000-00005
doi: 10.1097/ADM.0000000000000737
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
201-210Informations de copyright
Copyright © 2020 American Society of Addiction Medicine.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest
Références
Reid JL, Hammond D, Tariq U, Burkhalter R, Rynard VL, Douglas O. Tobacco Use in Canada: Patterns and Trends . Waterloo, ON: Propel Centre for Population Health Impact, University of Waterloo; 2019.
Chaiton M, Callard C. Mind the gap: disparities in cigarette smoking in Canada. Tobacco Use Insights 2019; 12:1–8.
Bandiera FC, Anteneh B, Le T, Delucchi K, Guydish J. Tobacco-related mortality among persons with mental health and substance abuse problems. PloS One 2015; 10 (3):e0120581.
Schroeder SA, Morris CD. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Ann Rev of Public Health 2010; 31:297–314.
Hser YI, McCarthy WJ, Anglin MD. Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Prev Med 1994; 23 (1):61–69.
Hurt RD, Offord KP, Croghan IT, et al. Mortality following inpatient addictions treatment: role of tobacco use in a community-based cohort. JAMA 1996; 275 (14):1097–1103.
Guydish J, Passalacqua E, Tajima B, Chan M, Chun J, Bostrom A. Smoking prevalence in addiction treatment: a review. Nicotine Tob Res 2011; 13 (6):401–411.
Guydish J, Tajima B, Chan M, Delucchi KL, Ziedonis D. Measuring smoking knowledge, attitudes and services (S-KAS) among clients in addiction treatment. Drug Alcohol Depend 2011; 114 (2–3):237–241.
Williams JM, Foulds J, Dwyer M, et al. The integration of tobacco dependence treatment and tobacco-free standards into residential addictions treatment in New Jersey. J Subst Abuse Treat 2005; 28 (4):331–340.
Prochaska JJ, Fletcher L, Hall SE, Hall SM. Return to smoking following a smoke-free psychiatric hospitalization. Am J Addict 2006; 15 (1):15–22.
Kohn CS, Tsoh JY, Weisner CM. Changes in smoking status among substance abusers: baseline characteristics and abstinence from alcohol and drugs at 12-month follow-up. Drug Alcohol Depend 2003; 69 (1):61–71.
Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol 2004; 72 (6):1144–1156.
Friend KB, Pagano ME. Smoking cessation and alcohol consumption in individuals in treatment for alcohol use disorders. J Addict Dis 2005; 24 (2):61–75.
Friend KB, Pagan ME. Changes in cigarette consumption and drinking outcomes: findings from Project MATCH. J Subst Abuse Treat 2005; 29 (3):221–229.
Das S, Hickman NJ, Prochaska JJ. Treating smoking in adults with co-occurring acute psychiatric and addictive disorders. J Addict Med 2017; 11 (4):273–279.
Thurgood SL, McNeill A, Clark-Carte D, Brose LS. A systematic review of smoking cessation interventions for adults in substance abuse treatment or recovery. Nicotine Tob Res 2016; 18 (5):993–1001.
Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev 2016; 11 (1):CD010274.
Reid RD, Mullen KA, Slovinec D’Angelo ME, et al. Smoking cessation for hospitalized smokers: an evaluation of the “Ottawa Model”. Nicotine Tob Res 2010; 12 (1):11–18.
Gadomski AM, Stayton M, Krupa N, Jenkins P. Implementing a smoke-free medical campus: impact on inpatient and employee outcomes. J Hosp Med 2010; 5 (1):51–54.
Guydish J, Yip D, Le T, Gubner NR, Delucchi K, Roman P. Smoking-related outcomes and associations with tobacco-free policy in addiction treatment, 2015–2016. Drug and Alcohol Dependence 2017; 179:355–361.
Pagano A, Guydis J, Le T, et al. Smoking behaviors and attitudes among clients and staff at New York Addiction Treatment Programs following a smoking ban: findings after 5 years. Nicotine Tob Res 2015; 18 (5):1274–1281.
Romano I, Costello MJ, Ropp C, et al. Evaluating the short-term impact of a tobacco-free policy in an inpatient addiction treatment setting. J Substance Abuse Treat 2019; 107:50–59.
Leatherdale ST. Natural experiment methodology for research: a review of how different methods can support real-world research. Int J Soc Res Methodol 2019; 22 (1):19–35.
Costello MJ, Ropp C, Sousa S, et al. The development and implementation of an outcome monitoring system for addiction treatment. Canadian J Addict 2016; 7 (3):15–24.
Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1998; 44:1049–1060.
Geronimi J, Saporta G. The effect of missing visits on GEE, a simulation study. Statistical, Stochastic and Data Analysis Methods & Applications. 2015;269.
SAS 9.4 [computer program]. Cary, NC: SAS Institute Inc. 2016.
Prochaska JJ. Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction? Drug Alcohol Depend 2010; 110 (3):177–182.
Bates ME, Voelbel GT, Buckman JF, Labouvie EW, Barry D. Short-term neuropsychological recovery in clients with substance use disorders. Alcohol Clin Exp Res 2005; 29 (3):367–377.
Wong SL, Shields M, Leatherdale S, Malaison E, Hammond D. Assessment of validity of self-reported smoking status. Health Rep 2012; 23 (1):47–53.
Yeager DS, Krosnick JA. The validity of self-reported nicotine product use in the 2001–2008 National Health and Nutrition Examination Survey. Med Care 2010; 48 (12):1128–1132.
Fendrich M, Mackesy-Amiti ME, Johnson TP, Hubbell A, Wislar JS. Tobacco-reporting validity in an epidemiological drug-use survey. Addictive Bbehaviors 2005; 30 (1):175–181.